Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SCND | Common Stock | Purchase | $250K | +250K | +20.78% | $1.00 | 1.45M | Apr 18, 2025 | See footnote | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SCND | Warrants to Purchase Common Stock | Purchase | +250K | 250K | Apr 18, 2025 | Common Stock | 250K | $1.00 | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share. |
F2 | This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. |